title: Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
abstract: BACKGROUND
  Bacterial persistence describes a phenomenon wherein a small subpopulation of cells is able to survive a challenge with high doses of an antibiotic (or other stressor) better than the majority of the population. Previous work has shown that cells that are in a dormant or slow-growing state are persistent to antibiotic treatment and that populations with higher fractions of dormant cells exhibit higher levels of persistence. These data suggest that a major determinant of the fraction of persisters within a population is the rate at which cells enter and exit from dormancy. However, it is not known whether there are physiological changes in addition to dormancy that influence persistence. Here, we use quantitative measurements of persister fractions in a set of environmental isolates of E. coli together with a mathematical model of persister formation to test whether a single general physiological change, such as cell dormancy, can explain the differences in persister phenotypes observed in different strains.
  
  
  RESULTS
  If a single physiological change (e.g. cell dormancy) underlies most persister phenotypes, then strains should exhibit characteristic fractions of persister cells: some strains will consistently have high fractions of persisters (dormant cells), whereas others will have low fractions. Although we found substantial variation in the fraction of persisters between different environmental isolates of E. coli, these fractions were not correlated across antibiotics. Some strains exhibited high persister fractions in one antibiotic, but low persister fractions in a second antibiotic. Surprisingly, no correlation in persister fractions was observed between any two drugs, even for antibiotics with nearly identical modes of action (ciprofloxacin and nalidixic acid).
  
  
  CONCLUSIONS
  These data support the hypothesis that there is no single physiological change that determines the persistence level in a population of cells. Instead, the fraction of cells that survive antibiotic treatment (persist) depends critically on the specific antibiotic that is used, suggesting that physiological changes in addition to dormancy can underlie persister phenotypes.
authors: Computational and Systems Biology, Biozentrum, University of Basel, Basel, Switzerland.
authors: Niels
authors: N
authors: Hofsteenge
authors: Erik
authors: E
authors: van Nimwegen
authors: Olin K
authors: OK
authors: Silander
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004783:Environmental Microbiology; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification / Q000502:physiology*; D050296:Microbial Viability / Q000187:drug effects*; D008962:Models, Theoretical
chemical_list: D000900:Anti-Bacterial Agents
references: J Bacteriol. 1998 Oct;180(20):5484-8
references: 9765586
references: J Bacteriol. 2006 Jul;188(14):5136-44
references: 16816185
references: Am Fam Physician. 2002 Feb 1;65(3):455-64
references: 11858629
references: Science. 2004 Sep 10;305(5690):1622-5
references: 15308767
references: Nat Rev Microbiol. 2007 Jan;5(1):48-56
references: 17143318
references: Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6145-9
references: 18427112
references: Annu Rev Microbiol. 2010;64:357-72
references: 20528688
references: Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31
references: 1650698
references: Antimicrob Agents Chemother. 2004 Oct;48(10):3670-6
references: 15388418
references: Science. 2011 Nov 18;334(6058):915-6
references: 22096180
references: J Bacteriol. 1983 Aug;155(2):768-75
references: 6348026
references: PLoS Genet. 2013;9(1):e1003123
references: 23300474
references: Evolution. 2012 Mar;66(3):933-939
references: 22380453
references: J Bacteriol. 2006 May;188(10):3494-7
references: 16672603
references: Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7200-5
references: 21482770
references: J Bacteriol. 2010 Jul;192(13):3379-84
references: 20435730
references: J Bacteriol. 2010 Dec;192(23):6191-9
references: 20935098
references: Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6
references: 15942878
references: J Bacteriol. 2006 Dec;188(24):8360-7
references: 17041039
references: mBio. 2011 Jun 14;2(3):e00100-11
references: 21673191
references: J Antimicrob Chemother. 2007 Feb;59(2):254-63
references: 17105735
references: Appl Environ Microbiol. 2006 Jan;72(1):612-21
references: 16391098
references: Nat Methods. 2010 Sep;7(9):737-9
references: 20676109
references: Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12275-80
references: 20566858
references: BMC Res Notes. 2009 Jan 07;2:2
references: 19128452
references: Antimicrob Agents Chemother. 2008 Aug;52(8):2718-26
references: 18519731
references: J Bacteriol. 2004 Dec;186(24):8172-80
references: 15576765
references: J Gen Microbiol. 1986 May;132(5):1297-304
references: 3534137
references: J Bacteriol. 2011 Jul;193(14):3598-605
references: 21602347
references: Antimicrob Agents Chemother. 1990 Oct;34(10):1938-43
references: 1963289
references: Science. 2012 Apr 20;336(6079):315-9
references: 22517853
references: J Bacteriol. 2006 Jun;188(11):3826-36
references: 16707675
references: J Bacteriol. 2010 Mar;192(5):1279-91
references: 20061486
references: Clin Pharmacol Ther. 2007 Aug;82(2):204-9
references: 17538551
references: BMC Microbiol. 2006 Jun 12;6:53
references: 16768798
references: PLoS Genet. 2009 Dec;5(12):e1000760
references: 20011100
references: Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13206-11
references: 21788497